Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

March 13, 2026 10:30 ET | Source: Profound Medical Corp.

CAPTAIN Trial Comparing Profound’s MRI-Guided TULSA Procedure™ to Robotic Radical Prostatectomy Successfully Meets Primary Safety Endpoint, Preservation of Erectile Function and Urinary Continence

– First multicenter, randomized controlled trial directly comparing a new technology to robotic RP for men with localized prostate cancer to successfully recruit to target enrollment – – TULSA...
January 13, 2000 08:15 ET | Source: Situs Corporation

Situs Corp. CEO W. Tate Scott Appointed To The Board Of The National Association For Continence

SOLANA BEACH, Calif., Jan. 13, 2000 (PRIMEZONE) -- Situs Corp., a pioneer of intravesical drug delivery, today announced that its Chief Executive Officer, W. Tate Scott, has been appointed to the...